b.harmony - Targeted probiotics for digestion

In stock
Regular price
€59,00
Sale price
€59,00
Regular price
€59,00

🖤 20% Black Friday discount applied in cart!

  • Free shipping
Bottles
Bottles: single pack

b.harmony is a targeted probiotic supplement designed to support digestion, even for individuals with histamine intolerance and celiac disease. It is free from lactose, gluten, and cow’s milk protein.

 

It has been shown to sustainably increase the number of lactobacilli and bifidobacteria in the gut.

 

It provides your body with beneficial probiotic bacteria and a dose of omega-3 fatty acids.

 

Thanks to the addition of omega-3 fatty acids, the friendly bacteria in b.harmony colonize the gut more effectively and remain active longer.
Omega-3 fatty acids are also known to enhance anti-inflammatory effects.

 

The probiotics in b.harmony capsules safely survive contact with stomach acid and bile.


They reach the intestines in excellent condition, ready to support your microbiome.
The bacterial strains are tested and proven to be resistant to gastric and bile acids, ensuring effectiveness even if the capsule dissolves in the stomach.

 

If swallowing capsules is difficult, they can be opened, and the contents mixed with a beverage.


Ingredients (per daily dose):

Bifidobacterium animalis lactis B1 – 3.33 x 10⁹ CFU

Bifidobacterium breve BL10 – 3.33 x 10⁹ CFU

Bifidobacterium breve Bbr8 – 3.33 x 10⁹ CFU

Lactobacillus paracasei 101/37 – 5 x 10⁹ CFU

Lactiplantibacillus plantarum 14D – 5 x 10⁹ CFU

Omega-3 fatty acids (EPA) – 136 mg

Omega-3 fatty acids (DHA) – 72 mg

Other fatty acids – 64 mg

L-lysine (amino acid) – 128 mg

 

Packaging leaflet

MVDr. Alojz Bomba, DrSc.

At the heart of Beie.’s innovation stands MVDr. Alojz Bomba, DrSc., co-founder and Chief Scientific Officer of PerBiotiX, and former head of Experimental Medicine at Pavol J. Šafárik University in Košice. With over 40 years of microbiome research, he pioneered the concept of targeted modulation of gut microbiota—a methodology now published and cited internationally. Prof. Bomba led major EU-funded projects studying probiotic and bioactive substances aimed at preventing conditions such as inflammatory bowel diseases, cancer, allergies, and metabolic disorders. He’s also the founder of the International Probiotics & Prebiotics Conference—one of the largest global gatherings of microbiome scientists.